Artiva Biotherapeutics (ARTV) Change in Account Payables (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported Change in Account Payables of $1.8 million for Q1 2026, up 4319.51% year-over-year from $41000.0 in Q1 2025, and up 1308.0% quarter-over-quarter from -$150000.0 in Q4 2025.
Artiva Biotherapeutics (ARTV) Change in Account Payables (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Change in Account Payables data on file, last reported at $1.8 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at $1.8 million, up 4319.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (up 447.42% YoY), and the FY2025 annual result was -$760000.0, down 246.44% from the prior year.
- Change in Account Payables improved to $1.8 million in Q1 2026 per ARTV's latest filing, from -$150000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $1.8 million in Q1 2026 and troughed at -$1.9 million in Q4 2023.
- A 4-year average of $112272.7 and a median of -$82000.0 in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2025 and 2026: Change in Account Payables slumped 162.78% in 2025, then soared 4319.51% in 2026.
- A 4-year view of Change in Account Payables shows it stood at -$1.9 million in 2023, then jumped by 95.73% to -$82000.0 in 2024, then tumbled by 82.93% to -$150000.0 in 2025, then jumped by 1308.0% to $1.8 million in 2026.
- Business Quant data shows ARTV's Change in Account Payables at $1.8 million in Q1 2026, -$150000.0 in Q4 2025, and -$442000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | 1.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.81 Mn |
| Mar 31, 2026 | 1.81 Mn |
| Dec 31, 2025 | -150,000.00 |
| Dec 31, 2025 | -150,000.00 |
| Sep 30, 2025 | -442,000.00 |
| Sep 30, 2025 | -442,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Jun 30, 2025 | -209,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | -82,000.00 |
| Dec 31, 2024 | -82,000.00 |
| Sep 30, 2024 | 704,000.00 |
| Sep 30, 2024 | 704,000.00 |
| Jun 30, 2024 | -954,000.00 |
| Jun 30, 2024 | -954,000.00 |
| Mar 31, 2024 | 851,000.00 |
| Mar 31, 2024 | 851,000.00 |
| Dec 31, 2023 | -1.92 Mn |
| Dec 31, 2023 | -1.92 Mn |